These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32532876)

  • 1. A recurrent de novo
    Cömert C; Brick L; Ang D; Palmfeldt J; Meaney BF; Kozenko M; Georgopoulos C; Fernandez-Guerra P; Bross P
    Cold Spring Harb Mol Case Stud; 2020 Jun; 6(3):. PubMed ID: 32532876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypomyelinating leukodystrophy-associated missense mutation in HSPD1 blunts mitochondrial dynamics.
    Miyamoto Y; Eguchi T; Kawahara K; Hasegawa N; Nakamura K; Funakoshi-Tago M; Tanoue A; Tamura H; Yamauchi J
    Biochem Biophys Res Commun; 2015 Jul; 462(3):275-81. PubMed ID: 25957474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial hsp60 chaperonopathy causes an autosomal-recessive neurodegenerative disorder linked to brain hypomyelination and leukodystrophy.
    Magen D; Georgopoulos C; Bross P; Ang D; Segev Y; Goldsher D; Nemirovski A; Shahar E; Ravid S; Luder A; Heno B; Gershoni-Baruch R; Skorecki K; Mandel H
    Am J Hum Genet; 2008 Jul; 83(1):30-42. PubMed ID: 18571143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60.
    Hansen JJ; Dürr A; Cournu-Rebeix I; Georgopoulos C; Ang D; Nielsen MN; Davoine CS; Brice A; Fontaine B; Gregersen N; Bross P
    Am J Hum Genet; 2002 May; 70(5):1328-32. PubMed ID: 11898127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence variants in SPAST, SPG3A and HSPD1 in hereditary spastic paraplegia.
    Svenstrup K; Bross P; Koefoed P; Hjermind LE; Eiberg H; Born AP; Vissing J; Gyllenborg J; Nørremølle A; Hasholt L; Nielsen JE
    J Neurol Sci; 2009 Sep; 284(1-2):90-5. PubMed ID: 19423133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic analysis of 20 patients with hypomyelinating leukodystrophy by trio-based whole-exome sequencing.
    Yan H; Ji H; Kubisiak T; Wu Y; Xiao J; Gu Q; Yang Y; Xie H; Ji T; Gao K; Li D; Xiong H; Shi Z; Li M; Zhang Y; Duan R; Bao X; Jiang Y; Burmeister M; Wang J
    J Hum Genet; 2021 Aug; 66(8):761-768. PubMed ID: 33597727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recurrent TMEM106B mutation in hypomyelinating leukodystrophy: A rapid diagnostic assay.
    Ikemoto S; Hamano SI; Kikuchi K; Koichihara R; Hirata Y; Matsuura R; Hiraide T; Nakashima M; Inoue K; Kurosawa K; Saitsu H
    Brain Dev; 2020 Sep; 42(8):603-606. PubMed ID: 32595021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypomyelinating Leukodystrophy due to HSPD1 Mutations: A New Patient.
    Kusk MS; Damgaard B; Risom L; Hansen B; Ostergaard E
    Neuropediatrics; 2016 Oct; 47(5):332-5. PubMed ID: 27405012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-nucleotide variations in the genes encoding the mitochondrial Hsp60/Hsp10 chaperone system and their disease-causing potential.
    Bross P; Li Z; Hansen J; Hansen JJ; Nielsen MN; Corydon TJ; Georgopoulos C; Ang D; Lundemose JB; Niezen-Koning K; Eiberg H; Yang H; Kølvraa S; Bolund L; Gregersen N
    J Hum Genet; 2007; 52(1):56-65. PubMed ID: 17072495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of the hereditary spastic paraplegia-associated Hspd1 gene encoding the Hsp60 chaperone results in early embryonic lethality in mice.
    Christensen JH; Nielsen MN; Hansen J; Füchtbauer A; Füchtbauer EM; West M; Corydon TJ; Gregersen N; Bross P
    Cell Stress Chaperones; 2010 Nov; 15(6):851-63. PubMed ID: 20393889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of the mitochondrial matrix proteases Lon and ClpP in cells from a patient with hereditary spastic paraplegia (SPG13).
    Hansen J; Corydon TJ; Palmfeldt J; Dürr A; Fontaine B; Nielsen MN; Christensen JH; Gregersen N; Bross P
    Neuroscience; 2008 May; 153(2):474-82. PubMed ID: 18378094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recurrent de novo mutation in TMEM106B causes hypomyelinating leukodystrophy.
    Simons C; Dyment D; Bent SJ; Crawford J; D'Hooghe M; Kohlschütter A; Venkateswaran S; Helman G; Poll-The BT; Makowski CC; Ito Y; Kernohan K; Hartley T; Waisfisz Q; Taft RJ; ; van der Knaap MS; Wolf NI
    Brain; 2017 Dec; 140(12):3105-3111. PubMed ID: 29186371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late onset motoneuron disorder caused by mitochondrial Hsp60 chaperone deficiency in mice.
    Magnoni R; Palmfeldt J; Christensen JH; Sand M; Maltecca F; Corydon TJ; West M; Casari G; Bross P
    Neurobiol Dis; 2013 Jun; 54():12-23. PubMed ID: 23466696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding the clinical and genetic spectra of NKX6-2-related disorder.
    Baldi C; Bertoli-Avella AM; Al-Sannaa N; Alfadhel M; Al-Thihli K; Alameer S; Elmonairy AA; Al Shamsi AM; Abdelrahman HA; Al-Gazali L; Shawli A; Al-Hakami F; Yavuz H; Kandaswamy KK; Rolfs A; Brandau O; Bauer P
    Clin Genet; 2018 May; 93(5):1087-1092. PubMed ID: 29388673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Hsp60-(p.V98I) mutation associated with hereditary spastic paraplegia SPG13 compromises chaperonin function both in vitro and in vivo.
    Bross P; Naundrup S; Hansen J; Nielsen MN; Christensen JH; Kruhøffer M; Palmfeldt J; Corydon TJ; Gregersen N; Ang D; Georgopoulos C; Nielsen KL
    J Biol Chem; 2008 Jun; 283(23):15694-700. PubMed ID: 18400758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel missense variant in HIKESHI: Clinical phenotype, in vitro functional testing, and potential for gene therapy.
    Mallack EJ; Wang C; Kim JS; Ross ME
    Am J Med Genet A; 2024 Nov; 194(11):e63790. PubMed ID: 38922739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the genotypic spectrum of PYCR2 and a common ancestry in Thai patients with hypomyelinating leukodystrophy 10.
    Manaspon C; Boonsimma P; Phokaew C; Theerapanon T; Sriwattanapong K; Porntaveetus T; Shotelersuk V
    Am J Med Genet A; 2021 Oct; 185(10):3068-3073. PubMed ID: 34037307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in NKX6-2 Cause Progressive Spastic Ataxia and Hypomyelination.
    Chelban V; Patel N; Vandrovcova J; Zanetti MN; Lynch DS; Ryten M; Botía JA; Bello O; Tribollet E; Efthymiou S; Davagnanam I; ; Bashiri FA; Wood NW; Rothman JE; Alkuraya FS; Houlden H
    Am J Hum Genet; 2017 Jun; 100(6):969-977. PubMed ID: 28575651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homozygous variants in pyrroline-5-carboxylate reductase 2 (PYCR2) in patients with progressive microcephaly and hypomyelinating leukodystrophy.
    Meng L; Donti T; Xia F; Niu Z; Al Shamsi A; Hertecant J; Al-Jasmi F; Gibson JB; Nagakura H; Zhang J; He W; Eng C; Yang Y; Elsea SH
    Am J Med Genet A; 2017 Feb; 173(2):460-470. PubMed ID: 27860360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cell model to study different degrees of Hsp60 deficiency in HEK293 cells.
    Bie AS; Palmfeldt J; Hansen J; Christensen R; Gregersen N; Corydon TJ; Bross P
    Cell Stress Chaperones; 2011 Nov; 16(6):633-40. PubMed ID: 21717087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.